Background: The management of intraductal papilloma without atypia (IDP) in breast needle
biopsy remains controversial. This study investigates the upgrade rate of IDP to carcinoma …

PURPOSE We aimed to estimate the upgrading rate of core-needle biopsy (CNB)-
diagnosed papillary breast lesions to atypical or malignant papillary lesions on subsequent …

A diagnosis of papilloma with atypia on core biopsy (CB) requires excision, as the risk of
associated malignancy is high (average 36.9%). The management of benign intraductal …

BACKGROUND The surgical management of mammary intraductal papilloma without atypia
(IDP) identified at core‐needle biopsy (CNB) is controversial. This study assessed the rate of …

BACKGROUND: The purpose of this study was to determine the accuracy of core needle
biopsy (CNB) diagnoses of papillary breast lesions, and to identify the risk factors and …

Objectives This study aims to evaluate the feasibility of Breast Lesion Excision System
(BLES) in the treatment of intraductal papillomas. Material and methods All patients with a …

Purpose To assess the reliability of percutaneous breast biopsies in diagnosing and
managing non malignant papillary lesions and determine if subsequent excision must be …

Background Current standard management for intraductal papilloma (IDP) diagnosed at
biopsy indicates complete surgical resection, but there are increasing controversies over …

Due to the potential for atypia (atypical ductal or lobular hyperplasia) or carcinoma (in situ or
invasive) on excision, aggressive reflex surgical excision protocols following core biopsy …

Background The recommendation for management of intraductal papilloma has not been
clearly established and its surgical excision criteria remain controversial. This study …